How many institutions held TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value in Q3 2021?

111 institutional investors reported TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value for Q3 2021. Use the holders table for investor-level position and value details.

Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH)

Q: What does CUSIP G8807B106 represent in this 13F holders report?

CUSIP G8807B106 is the security identifier for TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value used to aggregate holder disclosures.

CUSIP: G8807B106

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class: Equity / Ordinary Share $0.00001 Par Value
Shares outstanding: 51,428,000
Total 13F shares: 60,653,808
Share change: -106,060
Total reported value: $448,777,384
Put/Call ratio: 57%
Price per share: $7.40
Number of holders: 111
Value change: -$37,107,153
Number of buys: 68
Number of sells: 44

Quarterly Holders Quick Answers

What is CUSIP G8807B106?
CUSIP G8807B106 identifies TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2021
Previous quarter: Q2 2021

Recent filing periods for CUSIP G8807B106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	21%	10,791,863	$156,698,000	—	30 Jun 2021	13F
BAUPOST GROUP LLC/MA	13F	Company	19%	9,910,168	$143,896,000	—	30 Jun 2021	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	17%	8,727,324	$126,720,000	—	30 Jun 2021	13F
VANGUARD GROUP INC	13F	Company	10%	5,278,969	$76,651,000	—	30 Jun 2021	13F
ORBIMED ADVISORS LLC	13F	Company	8.9%	4,564,045	$66,270,000	—	30 Jun 2021	13F
BlackRock Finance, Inc.	13F	Company	8.8%	4,520,707	$65,640,000	—	30 Jun 2021	13F
Maven Securities LTD	13F	Company	2.6%	1,342,574	$20,125,000	—	30 Jun 2021	13F
Chescapmanager LLC	13F	Company	2.5%	1,261,718	$18,320,000	—	30 Jun 2021	13F
STATE STREET CORP	13F	Company	2.4%	1,256,058	$18,238,000	—	30 Jun 2021	13F
Laurion Capital Management LP	13F	Company	2.1%	1,094,936	$15,898,000	—	30 Jun 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.8%	932,268	$13,536,000	—	30 Jun 2021	13F
DAFNA Capital Management LLC	13F	Company	1.4%	732,345	$10,634,000	—	30 Jun 2021	13F
Rock Springs Capital Management LP	13F	Company	1.3%	687,500	$9,983,000	—	30 Jun 2021	13F
Tekla Capital Management LLC	13F	Company	1.3%	656,296	$9,529,000	—	30 Jun 2021	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	1.2%	591,524	$8,589,000	—	30 Jun 2021	13F
HIGHBRIDGE CAPITAL MANAGEMENT LLC	13F	Company	1.1%	587,666	$8,533,000	—	30 Jun 2021	13F
NORTHERN TRUST CORP	13F	Company	1.1%	560,901	$8,144,000	—	30 Jun 2021	13F
S.c.a. Candriam	13F	Individual	0.92%	475,696	$6,907,000	—	30 Jun 2021	13F
PEREGRINE CAPITAL MANAGEMENT LLC	13F	Company	0.89%	459,716	$6,675,000	—	30 Jun 2021	13F
MORGAN STANLEY	13F	Company	0.87%	447,969	$6,504,000	—	30 Jun 2021	13F
NORGES BANK	13F	Company	0.8%	410,611	$5,962,000	—	30 Jun 2021	13F
Woodline Partners LP	13F	Company	0.73%	374,912	$5,444,000	—	30 Jun 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.69%	356,544	$5,178,000	—	30 Jun 2021	13F
Cormorant Asset Management, LP	13F	Company	0.58%	300,000	$4,356,000	—	30 Jun 2021	13F
MACQUARIE GROUP LTD	13F	Company	0.56%	290,258	$4,215,000	—	30 Jun 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.56%	287,759	$4,179,000	—	30 Jun 2021	13F
Hudson Bay Capital Management LP	13F	Company	0.47%	240,437	$3,491,000	—	30 Jun 2021	13F
Altium Capital Management LLC	13F	Company	0.43%	220,000	$3,194,000	—	30 Jun 2021	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.41%	210,644	$3,059,000	—	30 Jun 2021	13F
Monashee Investment Management LLC	13F	Company	0.39%	200,000	$2,904,000	—	30 Jun 2021	13F
Bradford J. Shafer	3/4/5	EVP, Gen. Counsel, Secretary	— class O/S missing	277,831	$2,858,881	—	20 Aug 2021	3/4/5
WELLS FARGO & COMPANY/MN	13F	Company	0.37%	189,345	$2,750,000	—	30 Jun 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.36%	187,672	$2,725,000	—	30 Jun 2021	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.35%	179,200	$2,602,000	—	30 Jun 2021	13F
Bank of New York Mellon Corp	13F	Company	0.34%	175,359	$2,546,000	—	30 Jun 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.29%	150,551	$2,186,000	—	30 Jun 2021	13F
Swiss National Bank	13F	Company	0.23%	119,042	$1,728,000	—	30 Jun 2021	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	0.19%	96,000	$1,394,000	—	30 Jun 2021	13F
ExodusPoint Capital Management, LP	13F	Company	0.18%	90,864	$1,319,000	—	30 Jun 2021	13F
Russell Investments Group, Ltd.	13F	Company	0.16%	81,994	$1,190,000	—	30 Jun 2021	13F
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC	13F	Company	0.15%	79,290	$1,151,000	—	30 Jun 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.14%	73,457	$1,067,000	—	30 Jun 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.14%	71,572	$1,040,000	—	30 Jun 2021	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.14%	70,735	$1,027,000	—	30 Jun 2021	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.13%	65,600	$953,000	—	30 Jun 2021	13F
Hennion & Walsh Asset Management, Inc.	13F	Company	0.13%	65,246	$947,000	—	30 Jun 2021	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.12%	63,921	$928,133	—	30 Jun 2021	13F
CREDIT SUISSE AG/	13F	Company	0.12%	62,717	$910,000	—	30 Jun 2021	13F
CAAS CAPITAL MANAGEMENT LP	13F	Company	0.12%	61,450	$892,000	—	30 Jun 2021	13F
ROYCE & ASSOCIATES LP	13F	Company	0.11%	59,009	$857,000	—	30 Jun 2021	13F

Institutional Holders of Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH) as of Q3 2021

As of 30 Sep 2021, Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH) was held by 111 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 60,653,808 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, ORBIMED ADVISORS LLC, VANGUARD GROUP INC, BlackRock Inc., Madison Avenue Partners, LP, Point72 Asset Management, L.P., FMR LLC, Camber Capital Management LP, Woodline Partners LP, and Chescapmanager LLC. This page lists 112 institutional shareholders reporting positions in this security for the Q3 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders

101

Q3 2021 holders

111

Holder diff

Investor	Q2 2021 Shares	Q3 2021 Shares	Share Diff	Share Chg %	Q2 2021 Value $	Q3 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.